Company Data
Hoth Therapeutics Inc.
Ticker
HOTH
Current Price
$0.79 -4.59%
Market Cap
$5.5M
Price Target
Refer to Report
Volume
84.0K
52wk Range
$0.58 - $1.73
Overview
Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.